A Study Of Early Markers Of Choroidal Neovascularization

Clinical trial NCT00902785 · TERMINATED

Trial details

NCT number: NCT00902785
Sponsor: Pfizer
Status: TERMINATED
Study type: OBSERVATIONAL

Choroidal Neovascularization (CNV)Age-related Macular Degeneration (AMD)Early Markers

Start date: 2008-03-01
Primary completion: 2010-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.